Literature DB >> 25011443

Metabolite markers of incident CKD risk.

Eugene P Rhee1, Harold I Feldman2.   

Abstract

Keywords:  CKD; biomarkers

Mesh：

Substances：

Year:  2014        PMID： 25011443      PMCID： PMC4123393          DOI： 10.2215/CJN.05910614

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  16 in total

1.  Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35.

Authors:  Jinghong Wang; Nicole Simonavicius; Xiaosu Wu; Gayathri Swaminath; Jeff Reagan; Hui Tian; Lei Ling
Journal:  J Biol Chem       Date:  2006-06-05       Impact factor: 5.157

Review 2.  What is the clinical significance of 5-oxoproline (pyroglutamic acid) in high anion gap metabolic acidosis following paracetamol (acetaminophen) exposure?

Authors:  D B Liss; M S Paden; E S Schwarz; M E Mullins
Journal:  Clin Toxicol (Phila)       Date:  2013-10-11       Impact factor: 4.467

3.  Plasma metabolomic profiles in different stages of CKD.

Authors:  Vallabh O Shah; Raymond R Townsend; Harold I Feldman; Kirk L Pappan; Elizabeth Kensicki; David L Vander Jagt
Journal:  Clin J Am Soc Nephrol       Date:  2012-12-06       Impact factor: 8.237

4.  Plasma and urinary amino acid metabolomic profiling in patients with different levels of kidney function.

Authors:  Flore Duranton; Ulrika Lundin; Nathalie Gayrard; Harald Mischak; Michel Aparicio; Georges Mourad; Jean-Pierre Daurès; Klaus M Weinberger; Angel Argilés
Journal:  Clin J Am Soc Nephrol       Date:  2013-11-14       Impact factor: 8.237

5.  A combined epidemiologic and metabolomic approach improves CKD prediction.

Authors:  Eugene P Rhee; Clary B Clish; Anahita Ghorbani; Martin G Larson; Sammy Elmariah; Elizabeth McCabe; Qiong Yang; Susan Cheng; Kerry Pierce; Amy Deik; Amanda L Souza; Laurie Farrell; Carly Domos; Robert W Yeh; Igor Palacios; Kenneth Rosenfield; Ramachandran S Vasan; Jose C Florez; Thomas J Wang; Caroline S Fox; Robert E Gerszten
Journal:  J Am Soc Nephrol       Date:  2013-05-16       Impact factor: 10.121

6.  Serum metabolomic profiling and incident CKD among African Americans.

Authors:  Bing Yu; Yan Zheng; Jennifer A Nettleton; Danny Alexander; Josef Coresh; Eric Boerwinkle
Journal:  Clin J Am Soc Nephrol       Date:  2014-07-10       Impact factor: 8.237

7.  Metabolites associate with kidney function decline and incident chronic kidney disease in the general population.

Authors:  Oemer-Necmi Goek; Cornelia Prehn; Peggy Sekula; Werner Römisch-Margl; Angela Döring; Christian Gieger; Margit Heier; Wolfgang Koenig; Rui Wang-Sattler; Thomas Illig; Karsten Suhre; Jerzy Adamski; Anna Köttgen; Christa Meisinger
Journal:  Nephrol Dial Transplant       Date:  2013-06-05       Impact factor: 5.992

8.  Proapoptotic activity of indoleamine 2,3-dioxygenase expressed in renal tubular epithelial cells.

Authors:  Kanishka Mohib; Qiunong Guan; Hong Diao; Caigan Du; Anthony M Jevnikar
Journal:  Am J Physiol Renal Physiol       Date:  2007-07-03

Review 9.  1,5-anhydroglucitol (GlycoMark) as a marker of short-term glycemic control and glycemic excursions.

Authors:  Kathleen M Dungan
Journal:  Expert Rev Mol Diagn       Date:  2008-01       Impact factor: 5.225

10.  Uremic solutes and risk of end-stage renal disease in type 2 diabetes: metabolomic study.

Authors:  Monika A Niewczas; Tammy L Sirich; Anna V Mathew; Jan Skupien; Robert P Mohney; James H Warram; Adam Smiles; Xiaoping Huang; Walker Walker; Jaeman Byun; Edward D Karoly; Elizabeth M Kensicki; Gerard T Berry; Joseph V Bonventre; Subramaniam Pennathur; Timothy W Meyer; Andrzej S Krolewski
Journal:  Kidney Int       Date:  2014-01-15       Impact factor: 10.612
View more
  2 in total

1.  Metabolomics of Chronic Kidney Disease Progression: A Case-Control Analysis in the Chronic Renal Insufficiency Cohort Study.

Authors:  Eugene P Rhee; Clary B Clish; Julia Wenger; Jason Roy; Sammy Elmariah; Kerry A Pierce; Kevin Bullock; Amanda H Anderson; Robert E Gerszten; Harold I Feldman
Journal:  Am J Nephrol       Date:  2016-05-13       Impact factor: 3.754

Review 2.  Metabolomics and renal disease.

Authors:  Eugene P Rhee
Journal:  Curr Opin Nephrol Hypertens       Date:  2015-07       Impact factor: 2.894
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.